Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds
The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar strategic collaborations.
Comment & Opinion
Synthetic hormones and the future of contraception
First two medicinal products to undergo EU joint clinical assessments announced
The 7MM atopic dermatitis market to experience growth, reaching $22.4bn by 2033
Do in vivo CAR-T cell therapies have the potential to overtake ex vivo CAR-Ts?
ESCMID Global 2025: Climate-informed infectious disease risk management
COPD market projected to grow to $30.2bn in the 7MM by 2033
AAN 2025: Long-term outcome data on steroid regimens in MG may guide treatment standards
